- Open Access
In vivo and in vitro evaluation of an Acetobacter xylinum synthesized microbial cellulose membrane intended for guided tissue repair
© Mendes et al; licensee BioMed Central Ltd. 2009
- Received: 14 January 2009
- Accepted: 24 March 2009
- Published: 24 March 2009
Barrier materials as cellulose membranes are used for guided tissue repair. However, it is essential that the surrounding tissues accept the device. The present study histologically evaluated tissue reaction to a microbial cellulose membrane after subcutaneous implantation in mice. Furthermore, the interaction between mesenchymal stem cells and the biomaterial was studied in vitro to evaluate its ability to act as cellular scaffold for tissue engineering.
Twenty-five Swiss Albino mice were used. A 10 × 10 mm cellulose membrane obtained through biosynthesis using Acetobacter xylinum bacteria was implanted into the lumbar subcutaneous tissue of each mouse. The mice were euthanatized at seven, 15, 30, 60, and 90 days, and the membrane and surrounding tissues were collected and examined by histology.
A mild inflammatory response without foreign body reaction was observed until 30 days post-surgery around the implanted membrane. Polarized microscopy revealed that the membrane remained intact at all evaluation points. Scanning electron microscopy of the cellulose membrane surface showed absence of pores. The in vitro evaluation of the interaction between cells and biomaterial was performed through viability staining analysis of the cells over the biomaterial, which showed that 95% of the mesenchymal stem cells aggregating to the cellulose membrane were alive and that 5% were necrotic. Scanning electron microscopy showed mesenchymal stem cells with normal morphology and attached to the cellulose membrane surface.
The microbial cellulose membrane evaluated was found to be nonresorbable, induced a mild inflammatory response and may prove useful as a scaffold for mesenchymal stem cells.
- Mesenchymal Stem Cell
- Bacterial Cellulose
- Multinucleated Giant Cell
- Foreign Body Reaction
- Cellulose Membrane
The composition and structure of a membrane are important factors in determining its medical applications [1, 2]. Membranes constructed of synthetic or semisynthetic materials (polytetrafluoroethylene, expanded polytetrafluoroethylene, polylactic acid, copolymer of polylactic acid and polyglycolic acid, cellulose acetate, and others) or of natural origin (type I bovine collagen, porcine type I collagen, bovine type I atecollagen, and others) have been developed and tested, with some of them showing promising results as barrier material [3–7].
Barrier materials have been used to promote guided bone regeneration or guided tissue regeneration in maxillofacial bone defects, cranial defects, and periodontal bone defects [5–8]. The same biological concept has been used in the treatment of segmental defects in long bones [3, 9, 10]. Both resorbable and nonresorbable membranes have been developed, each of which with advantages and disadvantages. Within dentistry, the problems associated with nonresorbable barrier materials include requirement of a second surgical procedure for removal of the membrane besides gingival recession and membrane exposure . On the other hand, the resorbable membranes should preferably be resorbed in a time period that is predictable and compatible with the bone regeneration and the degradation should not interfere with bone regeneration .
Membranes composed of bacterial cellulose produced by Acetobacter species have been tested clinically and experimentally for different applications, such as wound dressing material, duraplasty, nerve anastomosis, artificial blood vessels or barrier to bone defects [2, 13–19]. Differences in the manufacturing according to initial concentrations of carbon sources, surface/volume ratios, strain of Acetobacter and extended times of fermentation interfere in the final product obtained [2, 19]. In addition, the choice of a particular cellulose structure will depend on the clinical application .
The multipotent mesenchymal stem cells are becoming a subject of increasing interest because of their potential in tissue engineering applications . They can be obtained from adult bone marrow and are capable to differentiate into other phenotypes including the cells of the bone, cartilage, tendons, ligaments, fat, and other connective tissues . According to tissue engineering concepts, it is possible to regenerate various tissues using living cells and an appropriate scaffold .
Thus, the aim of the present study was to histologically evaluate tissue reaction to a cellulose membrane obtained through biosynthesis using Acetobacter xylinum and its in vitro ability as scaffold to mesenchymal stem cells.
The membrane evaluated in this study was provided by the manufacturer (Bionext; São Paulo, Brazil). It is approved for medical use by the Brazilian Health Agency – ANVISA (register number 80255120001). The membrane is semi-transparent, flexible, hydrophilic, selective permeable, pH 6.0–7.0, 0.05 mm thick, and gamma radiation-sterilized.
Evaluation of membrane surface
For the evaluation of the biomaterial's surface, membrane pieces of 1 cm2 were submitted to scanning electron microscopy in a Quanta 200 3D Scanning Electron Microscope (Fei Company, Hillsboro, USA). No previous preparation of the samples was needed.
Tissue reaction evaluation
Twenty-five male Swiss Albino mice, approximately 1 month old and weighing 25 g were used. The animals were randomly divided into five groups according to postoperative observation points (G1 = 7 days, G2 = 15 days, G3 = 30 days, G4 = 60 days, G5 = 90 days). Each group of five mice was housed in a polyethylene cage (30 × 20 × 13 cm) with a stainless steel top. Commercial rat chow diet and water were provided ad libitum. Guidelines for the care and use of laboratory animals were followed and the study was approved by the Ethics Committee at the School of Veterinary Medicine and Animal Science, São Paulo State University.
Before surgery, anesthesia was induced by intramuscular injection of a combination of xylazine 2%, 10 mg/kg (Bayer S.A., São Paulo, SP, Brazil) and ketamine 5%, 150 mg/kg (Vetbrands Brasil Ltda., Paulínia, SP, Brazil). Each mouse was positioned in ventral recumbency and the lumbar area was prepared aseptically for surgery. A skin incision (1 cm) was made dorsolaterally in the right flank area. A piece of membrane (10 × 10 mm) was placed below the dorsal midline after blunt dissection through the subcutaneous tissues. Skin incision was closed using simple interrupted sutures of monofilament nylon 4-0. Buprenorphine (Schering Plough, Rio de Janeiro, RJ, Brazil) was administered intramuscularly immediately after surgical procedure (25 mg/kg).
Groups of five mice were euthanized at seven, 15, 30, 60, and 90 days post-surgery by intraperitoneal administration of an overdose of sodium pentobarbital. The membrane and surrounding tissues were collected and stored in 10% phosphate buffered formalin. After fixation, specimens were washed in tap water for 5 h, dehydrated in ethanol, cleared with xylene and embedded in paraffin. Histological sections of 5 μm thickness were stained with hematoxylin and eosin. The specimens were evaluated under polarized and light microscopy. Descriptive analysis of inflammatory infiltrate, vascular density and fibrosis was done. Semi-quantitative tissue analysis using previously established scores was performed as follows: absent (0), mild (1), intense (2), and severe (3).
The data were submitted to statistical analyses. Analysis of variance followed by the Tukey-Kramer Multiple Comparisons Test was used to evaluate the five different time points using the GraphPad InStat software. Differences were considered statistically significant at P < 0.05.
Biomaterial in cell culture
Canine bone marrow (5 ml obtained from the humerus) was collected for cell culture and centrifuged at 300 g for 10 min to remove serum and fat. The cell rich sediment was then diluted at the proportion of 1/1 with Dulbecco's Modified Eagle Medium (DMEM) high glucose with L-glutamin (GIBCO BRL; Grand Island, USA). Four ml were transferred to a tube containing 4 ml of Ficoll-Paque (1.077 g/ml) for density gradient centrifugation at 300 g for 40 min. After this, the mononuclear cell ring was collected and washed with DMEM twice. The cells were then diluted in 1 ml DMEM with 20% fetal calf serum (FCS) and transferred to culture bottles of 25 cm2 with 5 ml of DMEM (with L-glutamine), FCS, penicillin and streptomycin. Once the cells achieved 80% of sub-confluence at 15 days of culture, they were re-suspended to a concentration of 2 × 107 cells/ml.
To confirm the mesenchymal stem cell lineage, CD34 and CD44 specific surface antibodies (AbD Serotec, Oxford, UK) were used to mark mesenchymal cells. The cell populations isolated on primary culture were prepared according to the antibodies manufacturer protocols. The CD34 antibody FITC (Fluorescein Isothiocyanate) conjugated was negative at direct immunofluorescence staining for flow cytometry. The CD44 antibody associated to RPE secondary antibody (R. Phycoerythrin) was positive at indirect immunofluorescence staining for flow cytometry. The tests were performed by a flow cytometer (FACS Calibur – BD).
The microbial cellulose membrane was cut to fit into a 6-well plate. The membrane was damped with FCS and each well was filled with 5 ml of a medium containing DMEM, 20% FCS, penicillin, streptomycin and amphotericin B before mesenchymal stem cells were added. The stem cells were placed over the cellulose membrane at a concentration of 1–2 × 106 cells/ml. The cells were incubated at 37.5°C in a 5% CO2 atmosphere. The cell growth was followed over 10 days and the cells were subsequently submitted to cell viability staining with Hoescht 33342 (Sigma Chemical Co, St. Louis, USA) and Propidium Iodide (Sigma Chemical Co). Scanning electron microscopy was used to evaluate the cell attachment and growth. The membrane samples associated to the mesenchymal stem cells were removed from the 6-well plate and directly assessed in a Quanta 200 3D Scanning Electron Microscope (Fei Company, Hillsboro, USA). No previous preparation of the samples was needed.
Scores1attributed to the level of infiltration with polymorphonuclear cells (PMNs), multinucleated giant cells (MGCs), and lymphocytes, and development of angiogenesis and fibrosis at seven, 15, 30, 60 and 90 days post-operatively.
Time points of evaluation (days)
The chemical composition of a membrane intended for guided tissue repair determines the type, duration and degree of inflammatory and immune response, means of disintegration and its longevity in the host tissue . The inflammatory response may delay the healing process . In the present study a low inflammatory response to the implanted membrane was seen at seven, 15, and 30 days post-surgery with absence of foreign body reaction at any time, suggesting that the microbial cellulose membrane was well tolerated by the organism. Low cellular reaction was also found in a duraplasty study in dogs , and no gross or histological signs of inflammation including giant cell reaction were observed when pieces of bacterial cellulose membranes were implanted subcutaneously in rats for one to 12 weeks . In addition, the infection rate was decreased in humans that received cellulose membrane as wound and burn dressings . The absence of multinucleated giant cells suggests absence of foreign body reaction [1, 25]. Absence of foreign body reaction is important as such reactions may demand additional surgery for removal of the device .
In general, chemically nonreactive smooth-surfaced implants are surrounded by fibroblasts and collagen oriented parallel to the implant's surface within 2 weeks of implantation [1, 25]. Connective tissue surrounding but not penetrating the membrane was observed as early as 7 days postoperatively in the present study. Later on, especially 30 days after surgery, improved collagen deposition was seen. Similar enveloping of a cellulose membrane by connective tissue has been observed in association with duraplasty . Other authors have noticed that fibroblasts are able to penetrate the more porous bottom side of a cellulose membrane implanted into rats .
In the present study no signs of membrane structural changes or membrane absorption were detected by light and polarized light microscopy. In a clinical study comparing cellulose membrane and expanded polytetrafluoroethylene as barrier membrane in the treatment of class II furcation in human patients, both materials were removed 4 weeks after placement . On the other hand, in a duraplasty study in dogs the membrane was invaded by connective tissue and membrane filaments had loosened and separated from each other, resulting in its partial disappearance when evaluated 270 days postoperatively . Differences in production techniques probably influence the results [2, 19]. However, since the membrane used in the present experiment seems nonresorbable, problems associated with membrane durability may emerge .
Guided bone regeneration presents some requirements such as prevention of bacterial infection, maintenance of space beneath the barrier membrane, and separation of osteogenic cells from the competing nonosteogenic cells [1, 26]. Since the tested cellulose membrane was flexible, especially when wet, it is probably unable to prevent soft tissue collapse into a bony defect, which would necessitate the placement of a bone graft or biomaterial together with the membrane as a space-holder [1, 3]. This scenario was probably one of the factors that influenced the incomplete bone regeneration in circular defects performed on rabbit tibia .
Some authors describe the microbial cellulose membrane as highly porous material with pore sizes from several nanometers to micrometers . However, the absence of pores renders the membrane used in the present study cell-occlusive, suggesting that it will prevent cellular ingrowth from the adjacent connective tissue. In a study utilizing three different expanded polytetrafluoroethylene membrane qualities with different porosities placed on denuded rat calvaria, it was observed that there was a porosity range within which osteogenesis beneath the membrane is optimal, and the material with the smallest internodal distance did not integrate well with the surrounding soft tissue . Thus, the production of a microbial cellulose membrane with different pore sizes will be important according to its application.
Microbial cellulose membrane has been used as a scaffold to substances in order to augment its therapeutic properties . For example, Wan et al.  developed a microbial cellulose membrane coated with hydroxyapatite, an important compound for bone formation due to its osteoconductivity and bioactivity properties. In the present study, the mesenchymal stem cells aggregated to the cellulose membrane despite the difference of surface texture observed by electron microscopy thus demonstrating its ability to scaffold cells. The maintenance of normal mesenchymal stem cell morphology also suggested biocompatibility of the product. In a study using a cellulose membrane produced by Acetobacter aceti the growth of eight types of cells on the membrane was comparable to that obtained in plastics Petri dishes . However, both modification of the ionic charge and adsorption of collagen to membrane were used to promote cellular adhesion. Native and chemically modified bacterial cellulose materials from A xylinum was also evaluated as scaffold to chondrocytes suggesting a good potential . On the other hand, tissue culture and full-thickness transcortical bone defects induced in rat's mandible showed better results using expanded polytetrafluoroethylene than alkali-cellulose membrane that showed predominantly endochondral regeneration . According to the authors the alkali-cellulose membrane induced severe inflammatory reaction and appeared to disintegrate.
The tested microbial cellulose membrane was nonresorbable, induced low inflammatory response, and may be used as a scaffold for stem cells. Further investigations are necessary to confirm its use as barrier material.
- Linde A, Alberius P, Dahlin C, Bjurstam K, Sundin Y: Osteopromotion: a soft-tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontol. 1993, 64: 1116-1128.View ArticlePubMedGoogle Scholar
- Czaja WK, Young DJ, Kawecki M, Brown RM: The future prospects of microbial cellulose in biomedical applications. Biomacromolecules. 2007, 8: 1-12. 10.1021/bm060620d.View ArticlePubMedGoogle Scholar
- Zellin G, Linde A: Treatment of segmental defects in long bones using osteopromotive membranes and recombinant human bone morphogenetic protein-2. Scand J Plast Reconstr Surg Hand Surg. 1997, 31: 97-104.View ArticlePubMedGoogle Scholar
- Simonpietri-C JJ, Novaes AB, Batista EL, Filho EJF: Guided tissue regeneration associated with bovine-derived anorganic bone in mandibular class II furcation defects. 6-month results at re-entry. J Periodontol. 2000, 71: 904-911. 10.1902/jop.2000.71.6.904.View ArticlePubMedGoogle Scholar
- Lekovic V, Camargo PM, Weinlaender M, Kenney EB, Vasilic N: Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans. J Periodontol. 2001, 72: 583-589. 10.1902/jop.2001.72.5.583.View ArticlePubMedGoogle Scholar
- Stal S, Tjelmeland K, Hicks J, Bhatia N, Eppley B, Hollier L: Compartmentalized bone regeneration of cranial defects with biodegradable barriers: an animal model. J Craniofac Surg. 2001, 12: 41-47. 10.1097/00001665-200101000-00007.View ArticlePubMedGoogle Scholar
- Takata T, Wang HL, Miyauchi M: Migration of osteoblastic cells on various guided bone regeneration membranes. Clin Oral Impl Res. 2001, 12: 332-338. 10.1034/j.1600-0501.2001.012004332.x.View ArticleGoogle Scholar
- Kellomäki M, Niiranen H, Puumanen K, Ashammakhi N, Waris T, Törmälä P: Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials. 2000, 21: 2495-2505. 10.1016/S0142-9612(00)00117-4.View ArticlePubMedGoogle Scholar
- Meinig RP, Rahn B, Perren SM, Gogolewski S: Bone regeneration with resorbable polymeric membranes: treatment of diaphyseal bone defects in the rabbit radius with poly(L-Lactide) membrane. A pilot study. J Orthop Trauma. 1996, 10: 178-190. 10.1097/00005131-199604000-00006.View ArticlePubMedGoogle Scholar
- Teixeira JOC, Urist MR: Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects. Arch Orthop Trauma Surg. 1998, 117: 27-34. 10.1007/BF00703435.View ArticlePubMedGoogle Scholar
- Buser D, Bragger U, Lang NP, Nyman S: Regeneration and enlargement of jaw bone using guided tissue regeneration. Clin Oral Implants Res. 1990, 1: 22-32. 10.1034/j.1600-0501.1990.010104.x.View ArticlePubMedGoogle Scholar
- Aaboe M, Pinholt EM, Hjorting-Hansen E, Solheim E, Praetorius F: Guided tissue regeneration using degradable and non-degradable membranes in rabbit tibia. Clin Oral Impl Res. 1993, 4: 172-176. 10.1034/j.1600-0501.1993.040402.x.View ArticleGoogle Scholar
- Peixoto R, Santos DLN: Biofill: use and clinical evaluation of a cellulose graft in cutaneous lesions. Rev Bras Cir. 1988, 78: 141-145.Google Scholar
- Mello LR, Feltrin LT, Fontes Neto PT, Ferraz FA: Duraplasty with biosynthetic cellulose: an experimental study. J Neurosurg. 1997, 86: 143-150.View ArticlePubMedGoogle Scholar
- dos Anjos B, Novaes AB, Meffert R, Barboza EP: Clinical comparison of cellulose and expanded polytetrafluoroethylene membranes in the treatment of class II furcations in mandibular molars with 6-month re-entry. J Periodontol. 1998, 69: 454-459.View ArticlePubMedGoogle Scholar
- Salata LA, Hatton PV, Devlin AJ, Craig GT, Brook IM: In vitro and in vivo evaluation of e-PTFE and alkali-cellulose membranes for guided bone regeneration. Clin Oral Impl Res. 2001, 12: 62-68. 10.1034/j.1600-0501.2001.012001062.x.View ArticleGoogle Scholar
- Torres MFP, Graça DL, Farias ELP: Microsurgical repair of peripheral nerve by means of suture, fibrin glue or BioFill sheat in Wistar rats. Arq Bras Med Vet Zoo. 2003, 55: 557-561.View ArticleGoogle Scholar
- Macedo NL, Matuda FS, Macedo LGS, Monteiro ASF, Valera MC, Carvalho YR: Evaluation of two membranes in guided bone tissue regeneration: histological study in rabbits. Braz J Oral Sci. 2004, 3: 395-400.Google Scholar
- Czaja WK, Krystynowicz A, Bielecki S, Brown RM: Microbial cellulose–the natural power to heal wounds. Biomaterials. 2006, 27: 145-151. 10.1016/j.biomaterials.2005.07.035.View ArticlePubMedGoogle Scholar
- Awad HA, Butler DL, Boivin GP, Smith FNL, Malaviya P, Huibregtse B, Caplan AI: Autologous mesenchymal stem cell-mediated repair of tendon. Tis Eng. 1999, 5: 267-277. 10.1089/ten.1999.5.267.View ArticleGoogle Scholar
- Caplan AI: Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tis Eng. 2005, 11: 1198-1211. 10.1089/ten.2005.11.1198.View ArticleGoogle Scholar
- Boo JS, Yamada Y, Okazaki Y, Hibino Y, Okada K, Hata K, Yoshikawa T, Sugiura Y, Ueda M: Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofacial Surg. 2002, 13: 231-239. 10.1097/00001665-200203000-00009.View ArticleGoogle Scholar
- Mendenhall HV: Surgical Procedures. Handbook of Biomaterials Evaluations. Edited by: von Recum AF. 1999, Philadelphia: Taylor & Francis, 481-491.Google Scholar
- Helenius G, Bäckdahl H, Bodin A, Nannmark U, Gatenholm P, Risberg B: In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A. 2006, 76: 431-438.View ArticlePubMedGoogle Scholar
- Dee KC, Puleo DA, Bizios R: An Introduction to Tissue-Biomaterial Interactions. 2002, New Jersey: Wiley-LissView ArticleGoogle Scholar
- Nielsen FF, Karring T, Gogolewski S: Biodegradable guide for bone regeneration. Polyurethane membranes tested in rabbit radius defects. Acta Orthop Scand. 1992, 63: 66-69.View ArticleGoogle Scholar
- Zellin G, Linde A: Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials. 1996, 17: 695-702. 10.1016/0142-9612(96)86739-1.View ArticlePubMedGoogle Scholar
- Wan YZ, Huang Y, Yuan CD, Raman S, Zhu Y, Jiang HJ, He F, Gao C: Biomimetic synthesis of hydroxyapatite/bacterial cellulose nanocomposites for biomedical applications. Mater Sci Eng C. 2007, 27: 855-864. 10.1016/j.msec.2006.10.002.View ArticleGoogle Scholar
- Watanabe K, Eto Y, Takano S, Nakamori S, Shibai H, Yamanaka S: A new bacterial cellulose substrate for mammalian cell culture. Cytotechnology. 1993, 13: 107-114. 10.1007/BF00749937.View ArticlePubMedGoogle Scholar
- Svensson A, Nicklasson E, Harrah T, Panilaitis B, Kaplan DL, Brittberg M, Gatenholm P: Bacterial cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials. 2005, 26: 419-431. 10.1016/j.biomaterials.2004.02.049.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.